We report two cases of acute hepatitis induced by crizotinib in patients with ALK-rearranged non-small cell lung cancer (NSCLC) who were treated after by a second generation of ALK inhibitor without any incident. These cases suggest that ceritinib could be used as an alternative agent when crizotinib is responsible for hepatitis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.lungcan.2016.02.008 | DOI Listing |
Publication Analysis
Top Keywords
successful treatment
4
treatment ceritinib
4
ceritinib crizotinib
4
crizotinib induced
4
induced hepatitis
4
hepatitis report
4
report cases
4
cases acute
4
acute hepatitis
4
hepatitis induced
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!